Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 165,772 | 177,444 | 83,747 | 31,770 | 47,577 |
| Marketable Securities | 192,579 | 150,666 | 46,615 | 58,599 | 52,950 |
| Receivables | 95,567 | 136,015 | 324,692 | 185,854 | 61,543 |
| Inventories | 42,036 | 42,576 | 52,015 | 49,130 | 38,911 |
| Income taxes - deferred | 37,114 | 35,047 | 35,109 | 32,286 | 18,611 |
| Other current assets | 3,006 | 10,647 | 11,435 | 11,624 | 14,750 |
| TOTAL | $539,032 | $554,775 | $557,576 | $374,011 | $236,996 |
| Non-Current Assets | |||||
| PPE Net | 103,066 | 103,021 | 102,330 | 101,650 | 96,457 |
| Intangibles | 27,574 | 27,574 | 27,574 | 27,574 | 27,574 |
| Other Non-Current Assets | 35,214 | 162,752 | 157,549 | 157,521 | 168,866 |
| TOTAL | $165,854 | $293,347 | $287,453 | $286,745 | $292,897 |
| Total Assets | $704,886 | $848,122 | $845,029 | $660,756 | $529,893 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 19,156 | 20,291 | 33,249 | 23,295 | 13,245 |
| Accrued Expenses | 130,260 | 150,869 | 184,647 | 147,377 | 55,799 |
| TOTAL | $168,854 | $204,637 | $251,329 | $203,868 | $108,969 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 19,438 | 33,477 | 33,433 | 33,196 | 39,925 |
| Other Non-Current Liabilities | 13,673 | 12,074 | 12,184 | 10,176 | 16,767 |
| TOTAL | $50,418 | $236,381 | $231,939 | $234,661 | $240,178 |
| Total Liabilities | $219,272 | $441,018 | $483,268 | $438,529 | $349,147 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,242 | 63,436 | 62,613 | 62,022 | 61,875 |
| Common Shares | 638 | 637 | 627 | 622 | 618 |
| Retained earnings | 238,824 | 163,661 | 132,313 | 828 | -37,316 |
| Other shareholders' equity | 388 | 543 | -87 | -462 | -516 |
| TOTAL | $485,614 | $407,104 | $361,761 | $222,227 | $180,746 |
| Total Liabilities And Equity | $704,886 | $848,122 | $845,029 | $660,756 | $529,893 |